Réaction #1140

ord-90e66e44000e45b397f6a1aa0fe837fd

Équation de réaction

CN1C(=O)C(Br)(Br)CC1c1cncc(Br)c1
5-bromo-3-(3,3-dibromo-1-methyl-5-pyrrolidin-2-onyl)pyridine
[Te]
tellurium
[BH4-].[Na+]
Sodium borohydride
CCOC(C)=O
ethyl acetate
CN1C(=O)CCC1c1cncc(Br)c1
5-bromo-3-(1-methyl-5-pyrrolidin-2-onyl)pyridine
Rendement 68.0%

Solvants

Conditions de réaction

Conditions détaillées
See reaction.notes.procedure_details.

Traitement

  1. 1
    TempératureThe mixture was heated
  2. 2
    Températureunder reflux for 0.25 h
  3. 3
    Filtrationthe solution was filtered through Celite
  4. 4
    Concentrationconcentrated in vacuo
  5. 5
    workup.ADDITION1M HCl (10 mL) was added to the residue
  6. 6
    ExtractionAfter extraction with ethyl acetate (50 mL) the organic phase
  7. 7
    Autrewas separated
  8. 8
    ExtractionThe aqueous phase was extracted with ethyl acetate (2×50 mL)
  9. 9
    Lavagethe combined organic phases were washed with brine (30 mL)
  10. 10
    Séchagedried (MgSO4)
  11. 11
    Concentrationconcentrated
  12. 12
    AutreThis material was chromatographed on silica gel with ethyl acetate:hexane (1:1) as eluant

Mode opératoire

Sodium borohydride (862 mg, 22.8 mmol) was dissolved in ethanol (20 mL) and tellurium metal powder (1.45 g, 11.4 mmol) was added in portions. The mixture was heated under reflux for 0.25 h and 5-bromo-3-(3,3-dibromo-1-methyl-5-pyrrolidin-2-onyl)pyridine (775 mg, 1.9 mmol) was added to the solution at 25° C. After stirring for 2 h, ethyl acetate (50 mL) was added and the solution was filtered through Celite and concentrated in vacuo. 1M HCl (10 mL) was added to the residue and the solution was adjusted to pH 11 with solid potassium carbonate. After extraction with ethyl acetate (50 mL) the organic phase was separated. The aqueous phase was extracted with ethyl acetate (2×50 mL) and the combined organic phases were washed with brine (30 mL), dried (MgSO4) and concentrated. This material was chromatographed on silica gel with ethyl acetate:hexane (1:1) as eluant to afford 5-bromo-3-(1-methyl-5-pyrrolidin-2-onyl)pyridine as a solid (329 mg, 68%). M.p. 85°-87° C.; 1H NMR (CDCl3, 300 MHz): δ 8.66 (d, J=2 Hz, 1H), 8.42 (d, J=2 Hz, 1H), 7.68 (t, J=2 Hz, 1H), 4.56 (t, J=7 Hz, 1H), 2.71 (s, 3H), 2.45-2.65 (m, 2H), 1.80-1.95 (m, 2H).

Source

DOI: 10.6084/m9.figshare.5104873.v1Brevet: US05723477uspto-grants-1998_03